Tech Company Financing Transactions
AmnioChor Funding Round
On 8/3/2015, AmnioChor received Seed funding from Musculoskeletal Transplant Foundation.
Transaction Overview
Company Name
Announced On
8/3/2015
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Proceeds Purpose
The company intends to use the funds for the development of the proprietary AmnioCept product line and OmniBank placental tissue storage capabilities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Chicago, NJ 08742
USA
Chicago, NJ 08742
USA
Phone
Website
Email Address
Not Recorded
Overview
AmnioChor is a biotech company based in perinatal stem cell technology. The Company has identified a source and method of acquiring and preserving human stem cells. AmnioChor's stem cells will allow a tremendous expansion of the private stem cell storage industry and stem cell based therapies to augment the cord blood banking industry.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Russ Schweizer
Chief Medical Officer
Akiva Marcus
Chief Scientific Officer
Dale Woodbury
Browse more venture capital transactions:
Prev: 8/3/2015: Chewse venture capital transaction
Next: 8/3/2015: Fugue venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs